AU2001288847A1 - Conformationally constrained labeled peptides for imaging and therapy - Google Patents

Conformationally constrained labeled peptides for imaging and therapy

Info

Publication number
AU2001288847A1
AU2001288847A1 AU2001288847A AU8884701A AU2001288847A1 AU 2001288847 A1 AU2001288847 A1 AU 2001288847A1 AU 2001288847 A AU2001288847 A AU 2001288847A AU 8884701 A AU8884701 A AU 8884701A AU 2001288847 A1 AU2001288847 A1 AU 2001288847A1
Authority
AU
Australia
Prior art keywords
therapy
imaging
labeled peptides
conformationally constrained
conformationally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288847A
Inventor
Jack L. Erion
Michelle A. Schmidt
Ananthachari Srinivasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosyntema Inc
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of AU2001288847A1 publication Critical patent/AU2001288847A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001288847A 2000-09-07 2001-09-07 Conformationally constrained labeled peptides for imaging and therapy Abandoned AU2001288847A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23078900P 2000-09-07 2000-09-07
US60/230,789 2000-09-07
PCT/US2001/027708 WO2002020610A2 (en) 2000-09-07 2001-09-07 Conformationally constrained labeled peptides for imaging and therapy

Publications (1)

Publication Number Publication Date
AU2001288847A1 true AU2001288847A1 (en) 2002-03-22

Family

ID=22866588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288847A Abandoned AU2001288847A1 (en) 2000-09-07 2001-09-07 Conformationally constrained labeled peptides for imaging and therapy

Country Status (2)

Country Link
AU (1) AU2001288847A1 (en)
WO (1) WO2002020610A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ530156A (en) * 2001-07-10 2007-04-27 Ge Healthcare As Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents
IL148921A0 (en) * 2002-03-26 2002-09-12 Peptor Ltd Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents
NO20034350D0 (en) * 2003-09-29 2003-09-29 Amersham Health As Optical imaging of colorectal cancer
EP1729823B1 (en) 2004-03-04 2009-11-04 GE Healthcare AS Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs

Also Published As

Publication number Publication date
WO2002020610A2 (en) 2002-03-14
WO2002020610A3 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
AU2002245629A1 (en) Stabilized therapeutic and imaging agents
AU2001243710A1 (en) Imaging stretcher
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2001252504A1 (en) Combined impedance imaging and mammography
AU4082801A (en) Imaging apparatus
AU4248600A (en) Combined imaging and pdt delivery system
AU2001251114A1 (en) Enhancing contrast in biological imaging
AU2001278319A1 (en) Amyloid targeting imaging agents and uses thereof
AU6894700A (en) Therapeutic polypeptides and methods for using same
AU2002255952A1 (en) Short bioactive peptides and methods for their use
AU2001250889A1 (en) Patient weighing apparatus
AU2001287890A1 (en) Radiotherapy apparatus and collimator set therefor
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU2000268695A1 (en) Imaging apparatus
AU2002363944A1 (en) Alpha-fetoprotein peptides and uses for imaging
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001229439A1 (en) Bioconjugates and uses thereof
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AU2001288847A1 (en) Conformationally constrained labeled peptides for imaging and therapy
AU5836700A (en) Peptides for therapeutic use
AU2001249906A1 (en) Human transporters and ion channels
IL147731A0 (en) Peptide pharmaceutical formulations
AU2001249608A1 (en) Bladder cancer-specific peptides for diagnosis and therapy
AU3774000A (en) Conformationally constrained peptides